What can patents teach us about the potential impact of AI?

Researchers have found a new way to predict AI’s impact on the U.S. workforce: paying close attention to patents.

According to a recent analysis by researcher Michael Webb, “recognize,” “predict,” “detect,” “identify” and “determine” were the five most common verbs found in a study of more than 16,000 AI-related patents. A blog post from the Brookings Institution explained the importance of these findings.

“Since patents are predictions of future commercial relevance, Webb’s verb-object pairs come about as close as we can get to understanding how researchers and companies anticipate AI may be deployed,” according to the blog post. “And since applicants must pay nontrivial fees for filing patents, these words’ predictive value likely exceeds purely subjective expert assessment.”

The verbs highlighted by Webb’s report all sound like they could be describing an AI solution to be used in medical imaging—does this mean that could be an area of the U.S. workforce affected by AI?

Click the link below to learn more.  

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.